NewtekOne, Inc. logo NEWT - NewtekOne, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 2
HOLD 7
SELL 0
STRONG
SELL
0
| PRICE TARGET: $14.00 DETAILS
HIGH: $14.00
LOW: $14.00
MEDIAN: $14.00
CONSENSUS: $14.00
UPSIDE: 14.57%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 90% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Strong
Trading 58.9% below fair value
Current Price $12.22
Bear Case $20.83 70.5% upside ($20.83 - $12.22) / $12.22 = 70.5% ROTCE 11.9% → 1.01x TBV
Fair Value $29.76 143.5% upside ($29.76 - $12.22) / $12.22 = 143.5% ROTCE 15.8% → 1.52x TBV
Bull Case $38.69 216.6% upside ($38.69 - $12.22) / $12.22 = 216.6% ROTCE 18.2% → 1.83x TBV

Adjust Assumptions

15.8%
11.7%

Key Value Driver

ROTCE (15.8%) vs. cost of equity (11.7%)

Implied Market Multiple 0.92x

Plain-Language Summary

With ROTCE of 15.8% vs. 11.7% cost of equity, fair P/TBV is 1.52x on $13.26 tangible book, implying $29.76 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (9 analysts) $14.00
Analyst Range $14.00 – $14.00
Divergence from AlphaVal 113%

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $14.00 (from 9 analysts). Our estimate is 113% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly